Dr. Jagannath - ASH 2008 - Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma
Sundar Jagannath, MD St. Vincent's Comprehensive Cancer Center
New York, New York
USA Member, IMF Board of Scientific Advisors
01.14.09
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
back
button next to the volume control in the
lower right hand corner.
print
related articles